Ectopic pregnancy nursing: assessment, interventions, and NCLEX review

LS
By Lindsay Smith, AGPCNP
Updated April 20, 2026

Ectopic pregnancy occurs when a fertilized egg implants outside the uterine cavity — most often in a fallopian tube. It accounts for approximately 2% of all pregnancies in the United States and remains a leading cause of first-trimester maternal death, primarily from hemorrhagic shock following tubal rupture. For nursing students, ectopic pregnancy is a high-yield topic because it demands rapid pattern recognition, serial assessment skills, and clear patient education — all of which appear regularly on NCLEX.

This reference covers the full clinical picture: pathophysiology, risk stratification, diagnostic workup including β-hCG interpretation, medical versus surgical management, and the nursing priorities that protect patients from life-threatening complications.

Quick reference: ectopic pregnancy at a glance
Category Key facts
Prevalence ~2% of all US pregnancies; leading cause of first-trimester maternal mortality
Most common site Fallopian tube (~95%); ampullary portion most frequent (~70%)
Other sites Ovary, cervix, abdominal cavity, cesarean scar (rare)
Classic triad Amenorrhea + unilateral pelvic pain + abnormal vaginal bleeding
Key diagnostic tools Transvaginal ultrasound + serial β-hCG; discriminatory zone ~1,500–2,000 mIU/mL
Treatment options Medical (methotrexate) for unruptured; surgical (salpingectomy/salpingostomy) for ruptured or unstable
Top nursing priorities Hemorrhagic shock surveillance, IV access, Rh typing + RhoGAM, pain management, psychosocial support

Pathophysiology

Under normal circumstances, a fertilized egg travels through the fallopian tube over approximately 4–5 days, propelled by ciliary action and smooth-muscle peristalsis, before implanting in the uterine endometrium. When that transport is delayed or interrupted — by tubal scarring, anatomical distortion, or impaired ciliary function — implantation can occur before the egg reaches the uterus.

The fallopian tube lacks the structural adaptability of the uterus. As the trophoblast invades the thin tubal wall and the embryo grows, the tube stretches. Without intervention, the tubal wall eventually erodes. Rupture releases blood directly into the peritoneal cavity, triggering rapid hemorrhage. Because the peritoneal space can accommodate large volumes before hemodynamic instability becomes obvious, patients can deteriorate quickly once the threshold is crossed.

Blood pooling beneath the diaphragm causes referred shoulder pain (Kehr’s sign) — a finding that should prompt immediate escalation even in a patient who appears hemodynamically stable. The relationship between abdominal findings and peritoneal irritation is covered in more depth in the OB nursing reference.

Risk factors

Understanding risk factors allows nurses to identify at-risk patients early — before symptoms escalate to rupture. Risk factors broadly map to anything that impairs normal ovum transport or creates anatomical distortion.

Ectopic pregnancy risk factors by category
Category Risk factor Mechanism
Infectious / inflammatory Pelvic inflammatory disease (PID) Tubal scarring and impaired ciliary function from prior infection (Chlamydia trachomatis, Neisseria gonorrhoeae most common)
Prior STI (especially chlamydia) Silent tubal damage even without recognized PID
Endometriosis Peritubal adhesions impair ovum transport
Surgical / anatomical Prior ectopic pregnancy Highest individual risk factor; damaged tube predisposes to recurrence
Prior tubal surgery (including tubal ligation) Scarring and anatomical distortion of tube
Prior pelvic or abdominal surgery Adhesion formation alters tubal mobility and patency
Reproductive / contraceptive IUD use (if pregnancy occurs while IUD in place) IUD prevents intrauterine implantation but not ectopic; any pregnancy with IUD in situ is high risk for ectopic
Assisted reproductive technology (ART / IVF) Embryo transfer can migrate into tube; underlying tubal pathology common in this population
Progesterone-only contraception failure Reduces tubal motility; if contraceptive fails, implantation in tube is more likely
Lifestyle Cigarette smoking Nicotine impairs tubal ciliary beat frequency and smooth-muscle function
Age >35 Increased likelihood of prior tubal damage and reduced ciliary function

Clinical presentation

Classic triad

The textbook presentation combines three findings:

  1. Amenorrhea – Most patients have missed one menstrual period. A positive pregnancy test is expected, though very early ectopics may have low β-hCG levels.
  2. Unilateral pelvic pain – Initially crampy and intermittent; becomes sharp and severe with rupture. Diaphragmatic irritation from hemoperitoneum causes ipsilateral or bilateral shoulder pain (Kehr’s sign).
  3. Abnormal vaginal bleeding – Typically light, dark, and irregular (“spotting”). Heavy flow is unusual and should prompt consideration of an intrauterine source such as placenta previa or abruption.

Unruptured vs. ruptured presentation

The clinical picture shifts dramatically at the moment of tubal rupture:

Unruptured ectopic: Mild unilateral pain, possible vaginal spotting, hemodynamically stable. Patient may walk into the ED with vague symptoms. This is the window for medical management.

Ruptured ectopic: Sudden onset of severe abdominal pain (often described as “tearing”), signs of peritoneal irritation (rebound tenderness, guarding, rigid abdomen), referred shoulder pain, and — critically — signs of hemorrhagic shock. Recognize the shock progression: tachycardia → hypotension → pallor → diaphoresis → altered mental status. This is a surgical emergency. The hemorrhagic shock pathway overlaps with obstetric hemorrhage from other causes; see the postpartum hemorrhage nursing reference for the shared shock response framework.

Physical exam findings that increase suspicion: cervical motion tenderness on bimanual exam (Chandelier’s sign), adnexal mass or fullness, uterus smaller than expected for gestational age.

Diagnosis

β-hCG and the discriminatory zone

β-hCG (beta-human chorionic gonadotropin) is secreted by trophoblastic tissue and is the foundation of ectopic pregnancy diagnosis. Two principles guide interpretation:

Doubling rule: In a normal intrauterine pregnancy, β-hCG doubles approximately every 48–72 hours in early gestation. A rise of less than 53% over 48 hours (or a plateau/decline) is abnormal and raises suspicion for ectopic pregnancy or non-viable intrauterine pregnancy.

Discriminatory zone: The level at which a normal intrauterine pregnancy should be visible on transvaginal ultrasound. The ACOG-cited range is approximately 1,500–2,000 mIU/mL. If β-hCG is above this threshold and no intrauterine pregnancy is seen on ultrasound, ectopic pregnancy must be presumed until proven otherwise. See the nursing lab values cheat sheet for β-hCG reference ranges by gestational week.

Serial β-hCG measurements matter as much as a single value. A falling level combined with an empty uterus may represent a resolving early loss; a rising level without intrauterine implantation strongly points to ectopic.

Transvaginal ultrasound

Transvaginal ultrasound (TVUS) is the imaging study of choice. Findings are interpreted in three categories:

  • Definitive ectopic: Extrauterine gestational sac with or without cardiac activity
  • Suggestive: Adnexal mass, free fluid in the cul-de-sac (hemoperitoneum), empty uterus with β-hCG above discriminatory zone
  • Inconclusive: No intrauterine or extrauterine pregnancy identified (“pregnancy of unknown location”) — serial monitoring required

Progesterone

A serum progesterone level below 5 ng/mL is associated with non-viable pregnancy (intrauterine or ectopic). Levels above 25 ng/mL are reassuring for viable intrauterine pregnancy. Values between 5–25 ng/mL are indeterminate and require serial monitoring.

Additional labs

CBC (to establish baseline hemoglobin/hematocrit and detect occult blood loss), blood type and Rh factor, cross-match, metabolic panel, and coagulation studies if hemorrhage is suspected.

Treatment options

Management depends on hemodynamic stability, β-hCG level, ultrasound findings, gestational size, and patient preference. The two primary modalities are medical management with methotrexate and surgical intervention.

Treatment comparison: methotrexate vs. surgical management
Factor Methotrexate (medical) Salpingectomy / salpingostomy (surgical)
Mechanism Folate antagonist — inhibits DNA synthesis, halts trophoblast proliferation Salpingectomy: removal of affected tube. Salpingostomy: incision, embryo removed, tube preserved
Route / dosing Single-dose IM: 50 mg/m² body surface area (most common protocol). Multi-dose protocol used in select cases Laparoscopic preferred (less blood loss, faster recovery); laparotomy for hemodynamic instability
Indications Hemodynamically stable; unruptured ectopic; β-hCG generally <5,000 mIU/mL (guidelines vary); no contraindications to MTX Ruptured ectopic; hemodynamic instability; β-hCG >5,000 mIU/mL; medical management contraindicated or failed; patient preference
Contraindications (MTX) Intrauterine pregnancy; immunodeficiency; hepatic disease; renal impairment; active peptic ulcer disease; breastfeeding; inability to comply with follow-up No absolute contraindications in emergency setting; relative: desire to preserve fertility (favor salpingostomy)
Key nursing considerations Confirm no IUP before administering; obtain CBC, LFTs, creatinine pre-treatment; educate on avoidance (NSAIDs, folic acid, alcohol, sunlight); serial β-hCG follow-up mandatory Pre-op prep: IV access, type and crossmatch, consent, NPO; post-op: wound monitoring, pain management, DVT prophylaxis, emotional support
Follow-up requirement Serial β-hCG on days 4 and 7 post-treatment; weekly until <5 mIU/mL; may take weeks to months Routine post-surgical follow-up; no serial β-hCG required unless concern for persistent trophoblastic tissue (more common after salpingostomy)
Future fertility Preserved if tube remains intact and patent Salpingectomy reduces future ipsilateral fertility; salpingostomy preserves tube but has higher persistent ectopic rate (~5–8%)

Nursing assessment and interventions

Systematic nursing care for ectopic pregnancy centers on five priorities.

1. Hemodynamic monitoring and hemorrhagic shock prevention

Establish continuous vital sign monitoring from the moment ectopic pregnancy is suspected. The most lethal complication is hemorrhagic shock from tubal rupture. Know the early warning signs and escalate before the patient decompensates:

  • Tachycardia (HR >100 bpm) is the earliest reliable indicator of hypovolemia
  • Orthostatic hypotension precedes supine hypotension — check lying and standing if patient is stable enough
  • Narrowing pulse pressure signals increased peripheral vascular resistance in compensation
  • Decreasing urine output (<0.5 mL/kg/hr) reflects renal hypoperfusion
  • Sudden increase in abdominal or shoulder pain in a known ectopic patient should be treated as rupture until proven otherwise

For IV access guidance in emergency management, see the IV insertion reference. Establish at minimum one large-bore peripheral IV (18-gauge or larger). Two large-bore IVs in the antecubital fossa are preferred for patients at high rupture risk.

Have type and crossmatch drawn early — before hemodynamic deterioration. Keep 2–4 units packed red blood cells available if surgical intervention is likely. The approach to shock assessment mirrors the framework in the sepsis nursing reference, with the key distinction that hemorrhagic shock has a mechanical/volume cause rather than a distributive one.

2. Pain assessment and management

Administer analgesics as ordered. Document pain character, location, and trajectory — unilateral pelvic pain that becomes bilateral or radiates to the shoulder indicates expanding hemoperitoneum and requires immediate provider notification.

Avoid masking pain in a way that delays recognition of rupture. Reassess pain frequently (every 30–60 minutes in the unstable patient).

3. Rh factor and RhoGAM administration

Every patient with ectopic pregnancy must have blood type and Rh factor determined. Rh-negative patients who experience any trophoblastic loss — including ectopic pregnancy — are at risk for Rh sensitization if the fetus is Rh-positive. Sensitization has no effect on the current pregnancy but causes hemolytic disease of the fetus/newborn (HDFN) in subsequent Rh-positive pregnancies.

RhoGAM (Rho[D] immune globulin) must be administered to Rh-negative patients within 72 hours of the ectopic pregnancy diagnosis or intervention. Standard dose for first-trimester events is 50 mcg (microdose) IM, though some facilities use the standard 300 mcg dose. Confirm with the provider and institutional protocol.

This intervention is often tested on NCLEX and is easy to overlook under clinical pressure. Add it to the standard workflow for every antepartum loss.

4. Emotional and psychosocial support

Ectopic pregnancy is a pregnancy loss — often the first pregnancy the patient has known about, often wanted. The grief response is real and may be complicated by the life-threatening nature of the event, the need for rapid decision-making, and the implications for future fertility (particularly after salpingectomy).

Acknowledge the loss explicitly. Avoid language that focuses only on the clinical problem (“the tube”) and omits the pregnancy. Provide information about grief support resources and community organizations. Ensure a follow-up plan includes emotional as well as physical check-ins.

5. Pre-operative preparation (if surgical management indicated)

  • Confirm NPO status and duration
  • Obtain IV access, type and crossmatch, consent
  • Insert Foley catheter as ordered
  • Remove jewelry, prepare surgical site
  • Confirm medication reconciliation — note any anticoagulants, NSAIDs, or supplements
  • Communicate Rh status to surgical team

Methotrexate post-discharge teaching

Patients discharged on methotrexate require detailed education. Non-compliance with restrictions can reduce treatment efficacy or mask the signs of rupture. Use the table below as the basis for discharge teaching.

Methotrexate post-discharge instructions
Restriction Duration Reason
Avoid NSAIDs (ibuprofen, naproxen) Until treatment is complete (β-hCG <5 mIU/mL) NSAIDs reduce methotrexate clearance and can potentiate toxicity; also mask pain that may signal rupture
Avoid folic acid supplements (including prenatal vitamins) Until treatment is complete Methotrexate works by blocking folate metabolism; supplemental folic acid directly antagonizes the drug's mechanism
Avoid alcohol Until treatment is complete Hepatotoxicity risk; alcohol can also mask abdominal pain that signals rupture
Avoid prolonged sun exposure; use SPF 30+ Until treatment is complete Methotrexate causes photosensitivity; sun exposure can precipitate skin rash or burns
Avoid sexual intercourse and vigorous exercise Until treatment is complete and β-hCG has resolved Physical stress and intercourse increase risk of tubal rupture before the ectopic has fully resolved
No new pregnancy for at least 3 months (some guidelines recommend 3–6 months) Minimum 3 months post-treatment Teratogenic risk: methotrexate is a folate antagonist and is teratogenic if pregnancy occurs during the washout period
Serial β-hCG monitoring Weekly until <5 mIU/mL Confirms treatment success; persistent or rising levels indicate treatment failure or residual trophoblastic tissue requiring repeat dosing or surgery
Return immediately if: severe abdominal pain, shoulder pain, heavy vaginal bleeding, dizziness, fainting Throughout treatment period These are signs of tubal rupture — a surgical emergency even during medical management

Separation pain (days 3–7): Warn patients that cramping and increased pelvic pain is common 3–7 days after methotrexate injection. This “separation pain” reflects trophoblast breakdown and is expected. It is managed with acetaminophen — not NSAIDs. Pain that escalates beyond what acetaminophen controls, or that is accompanied by shoulder pain or hemodynamic symptoms, requires emergency evaluation.

NCLEX tips

The following are the highest-yield points for NCLEX preparation on ectopic pregnancy:

  1. The classic triad is your first clinical anchor. Amenorrhea + unilateral pelvic pain + abnormal vaginal bleeding = ectopic pregnancy until proven otherwise. On a NCLEX stem, any pregnant patient presenting with these three findings should trigger ectopic pregnancy as your primary concern.

  2. Shoulder pain = hemoperitoneum. Referred shoulder pain (Kehr’s sign) is caused by blood irritating the diaphragm. On NCLEX, if a pregnant patient mentions shoulder pain alongside abdominal pain, the answer almost always involves recognizing rupture and escalating to immediate surgical intervention.

  3. RhoGAM for every Rh-negative patient — within 72 hours. This is a consistent NCLEX target. The question may ask which intervention is priority, or which order to question — know that RhoGAM is mandatory for Rh-negative patients following any trophoblastic event, including ectopic pregnancy.

  4. Methotrexate contraindications are tested frequently. The most commonly tested are: existing intrauterine pregnancy, renal impairment, hepatic disease, immunodeficiency, peptic ulcer disease, and breastfeeding. A question showing a patient with elevated creatinine or liver enzymes being offered methotrexate should be flagged as inappropriate.

  5. Methotrexate restrictions — the why matters. NCLEX tests understanding, not just recall. Know why folic acid is avoided (it antagonizes the drug’s mechanism), why NSAIDs are avoided (reduce clearance, mask rupture pain), and why new pregnancy must wait at least 3 months (teratogenicity during washout).

  6. β-hCG above discriminatory zone + empty uterus = ectopic until proven otherwise. The discriminatory zone is approximately 1,500–2,000 mIU/mL. A question showing a β-hCG of 2,500 with no intrauterine pregnancy on ultrasound is testing whether you recognize this as presumptive ectopic.

  7. Separation pain vs. rupture — distinguish them. Mild cramping 3–7 days after methotrexate is expected (separation pain, managed with acetaminophen). Severe pain, shoulder pain, or hemodynamic changes during this same window = rupture. NCLEX may present both and ask which patient requires immediate intervention.

  8. Tachycardia is the first sign of hemorrhagic shock. In any question about a patient with ectopic pregnancy, a heart rate of 110 bpm with normal blood pressure should be treated as early hemorrhagic shock — not reassurance that the patient is stable.

For broader obstetric nursing context, the OB nursing reference covers the full antepartum and intrapartum spectrum including physiological changes of pregnancy and obstetric emergencies.

Ectopic pregnancy is one of several conditions on the antepartum bleeding differential. The placenta previa and abruption nursing reference covers the other major causes of antepartum hemorrhage and the nursing distinctions between them.

Hemorrhagic shock management principles — including volume resuscitation sequencing and shock staging — are covered in depth in the postpartum hemorrhage nursing reference.

When interpreting serial β-hCG values or reviewing lab thresholds for diagnosis, the nursing lab values cheat sheet provides a quick reference for normal ranges and clinically significant thresholds.

For IV access technique and considerations in emergent situations, see the IV insertion reference.